Related Articles
Genetic mutations and expression of p53 in non-invasive breast lesions
C-erbB-2 expression is a better predictor for survival than galectin-3 or p53 in early-stage breast cancer
Expression of the c-erb-B2 and p53 protein in gallbladder carcinomas
Breast carcinomas expressing basal markers have poor clinical outcome regardless of estrogen receptor status
Fibroblast growth factor receptor 3 protein expression in urothelial carcinoma of the urinary bladder, exhibiting no association with low-grade and/or non-invasive lesions